Glucose Dehydrogenase Assay Kits

Assay Principle

Glucose dehydrogenase (GDH, EC 1.1.1.118) catalyzes the oxidation of D-glucose to D-glucono-1,5-lactone, using NAD+ as an electron acceptor to generate NADH. A GDH assay typically couples this glucose oxidation to a colorimetric readout: as GDH converts glucose to gluconolactone, the NADH generated (or, in dye-coupled formats, an intermediate electron carrier) drives reduction of a chromogenic developer to a colored product with absorbance typically read around 450 nm. This kinetic, rate-based readout allows GDH activity to be calculated directly from the slope of absorbance change over time, and because the reaction is enzyme-specific for glucose as substrate, background interference from other reducing sugars is generally minimal.

Protocol highlights and purchasing considerations

Protocol Highlights

Beyond its relevance to basic carbohydrate metabolism research, GDH is of particular interest in point-of-care glucose biosensor development, where recombinant bacterial GDH is often favored over glucose oxidase because it is not oxygen-dependent, and in industrial biocatalysis applications relying on cofactor regeneration. Kits validated across cell culture supernatant, plasma, serum, and urine report sensitivity down to roughly 0.01 mU, with total assay time ranging from about 30 minutes to 2 hours depending on the developer chemistry and whether an endpoint or kinetic read format is used. Because the colorimetric developer reagent in some formats is prone to oxidation once reconstituted, protocols generally specify that it be prepared fresh immediately before use rather than stored for repeat assays, a detail worth confirming during protocol planning to avoid inconsistent day-to-day readings. Kits typically ship with a lyophilized positive control and an NADH standard, which supports proper standard curve generation and lot-to-lot verification of enzyme activity units.

Assay Kit Purchasing Considerations

Because the underlying glucose oxidation and NAD+-coupled chemistry used to measure glucose dehydrogenase activity is broadly consistent across suppliers, the more meaningful differentiators are validated sample matrix, reagent stability requirements, and whether the kit is formatted for microplate versus cuvette-based reads. Researchers developing or validating recombinant GDH constructs for biosensor applications should pay particular attention to whether a given kit's chromogenic detection chemistry could interfere with any electron-mediator compounds already present in a biosensor formulation. For general metabolic or industrial biocatalysis applications, confirming that a kit's sensitivity floor comfortably captures the expected activity range of the enzyme preparation under study, whether native tissue-derived or recombinant, is a reasonable first screening step. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.